UBS Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $52
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and lowers the price target from $54 to $52.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and lowers the price target from $54 to $52.
Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $50 to $48.
Filed: 2026-10-05 AccNo: 0001104659-26-113450 Size: 240 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-21 AccNo: 0002001184-26-000034 Size: 401 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
PACS Group announced definitive agreements to acquire operations of 32 skilled nursing facilities across Florida with 4,049 licensed beds from Omega Healthcare Investors subsidiaries. The transaction, expected to close in Q4 2026, expands PACS's presence in the high-growth post-acute care market and establishes a statewide network in Florida. The acquisition complements PACS's existing Southern footprint across Texas, South Carolina, Tennessee, and Kentucky.